1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Artificial Pancreas Device System Market, by Device Type
7.1.1. Thresholds Suspend Systems
7.1.1.1. Market Revenue and Forecast
7.1.2. Predictive Low Glucose Suspend Systems
7.1.2.1. Market Revenue and Forecast
7.1.3. Advanced Hybrid Closed-Loop Systems
7.1.3.1. Market Revenue and Forecast
7.1.4. Hybrid Closed-Loop Systems
7.1.4.1. Market Revenue and Forecast
7.1.5. Fully Closed-Loop Systems
7.1.5.1. Market Revenue and Forecast
8.1. Artificial Pancreas Device System Market, by Component
8.1.1. Continuous Glucose Monitoring Sensors
8.1.1.1. Market Revenue and Forecast
8.1.2. Insulin Pumps
8.1.2.1. Market Revenue and Forecast
8.1.3. Control Algorithms and Software
8.1.3.1. Market Revenue and Forecast
8.1.4. Infusion Sets and Consumables
8.1.4.1. Market Revenue and Forecast
9.1. Artificial Pancreas Device System Market, by Treatment Type
9.1.1. Insulin-only Systems
9.1.1.1. Market Revenue and Forecast
9.1.2. Bihormonal Systems
9.1.2.1. Market Revenue and Forecast
10.1. Artificial Pancreas Device System Market, by End User
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Specialty Diabetes Clinics
10.1.2.1. Market Revenue and Forecast
10.1.3. Home Care Settings
10.1.3.1. Market Revenue and Forecast
10.1.4. Ambulatory Care Centers
10.1.4.1. Market Revenue and Forecast
11.1. Artificial Pancreas Device System Market, by Age Group
11.1.1. Pediatric Patients
11.1.1.1. Market Revenue and Forecast
11.1.2. Adult Patients
11.1.2.1. Market Revenue and Forecast
11.1.3. Geriatric Patients
11.1.3.1. Market Revenue and Forecast
12.1. Artificial Pancreas Device System Market, by Distribution Channel
12.1.1. Direct Sales
12.1.1.1. Market Revenue and Forecast
12.1.2. Retail Pharmacies
12.1.2.1. Market Revenue and Forecast
12.1.3. Online Pharmacies
12.1.3.1. Market Revenue and Forecast
12.1.4. Hospital Pharmacies
12.1.4.1. Market Revenue and Forecast
13.1. Artificial Pancreas Device System Market, by Connectivity and Integration
13.1.1. Standalone Systems
13.1.1.1. Market Revenue and Forecast
13.1.2. Smartphone Integrated Systems
13.1.2.1. Market Revenue and Forecast
13.1.3. Cloud-connected Systems
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Device Type
14.1.2. Market Revenue and Forecast, by Component
14.1.3. Market Revenue and Forecast, by Treatment Type
14.1.4. Market Revenue and Forecast, by End User
14.1.5. Market Revenue and Forecast, by Age Group
14.1.6. Market Revenue and Forecast, by Connectivity and Integration
14.1.7. Market Revenue and Forecast, by Distribution Channel
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Device Type
14.1.8.2. Market Revenue and Forecast, by Component
14.1.8.3. Market Revenue and Forecast, by Treatment Type
14.1.8.4. Market Revenue and Forecast, by End User
14.1.8.5. Market Revenue and Forecast, by Age Group
14.1.8.6. Market Revenue and Forecast, by Connectivity and Integration
14.1.8.7. Market Revenue and Forecast, by Distribution Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Device Type
14.1.9.2. Market Revenue and Forecast, by Component
14.1.9.3. Market Revenue and Forecast, by Treatment Type
14.1.9.4. Market Revenue and Forecast, by End User
14.1.9.5. Market Revenue and Forecast, by Age Group
14.1.9.6. Market Revenue and Forecast, by Connectivity and Integration
14.1.9.7. Market Revenue and Forecast, by Distribution Channel
14.2. Europe
14.2.1. Market Revenue and Forecast, by Device Type
14.2.2. Market Revenue and Forecast, by Component
14.2.3. Market Revenue and Forecast, by Treatment Type
14.2.4. Market Revenue and Forecast, by End User
14.2.5. Market Revenue and Forecast, by Age Group
14.2.6. Market Revenue and Forecast, by Connectivity and Integration
14.2.7. Market Revenue and Forecast, by Distribution Channel
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Device Type
14.2.8.2. Market Revenue and Forecast, by Component
14.2.8.3. Market Revenue and Forecast, by Treatment Type
14.2.8.4. Market Revenue and Forecast, by End User
14.2.8.5. Market Revenue and Forecast, by Age Group
14.2.8.6. Market Revenue and Forecast, by Connectivity and Integration
14.2.8.7. Market Revenue and Forecast, by Distribution Channel
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Device Type
14.2.9.2. Market Revenue and Forecast, by Component
14.2.9.3. Market Revenue and Forecast, by Treatment Type
14.2.9.4. Market Revenue and Forecast, by End User
14.2.9.5. Market Revenue and Forecast, by Age Group
14.2.9.6. Market Revenue and Forecast, by Connectivity and Integration
14.2.9.7. Market Revenue and Forecast, by Distribution Channel
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Device Type
14.2.10.2. Market Revenue and Forecast, by Component
14.2.10.3. Market Revenue and Forecast, by Treatment Type
14.2.10.4. Market Revenue and Forecast, by End User
14.2.10.5. Market Revenue and Forecast, by Age Group
14.2.10.6. Market Revenue and Forecast, by Connectivity and Integration
14.2.10.7. Market Revenue and Forecast, by Distribution Channel
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Device Type
14.2.11.2. Market Revenue and Forecast, by Component
14.2.11.3. Market Revenue and Forecast, by Treatment Type
14.2.11.4. Market Revenue and Forecast, by End User
14.2.11.5. Market Revenue and Forecast, by Age Group
14.2.11.6. Market Revenue and Forecast, by Connectivity and Integration
14.2.11.7. Market Revenue and Forecast, by Distribution Channel
14.3. APAC
14.3.1. Market Revenue and Forecast, by Device Type
14.3.2. Market Revenue and Forecast, by Component
14.3.3. Market Revenue and Forecast, by Treatment Type
14.3.4. Market Revenue and Forecast, by End User
14.3.5. Market Revenue and Forecast, by Age Group
14.3.6. Market Revenue and Forecast, by Connectivity and Integration
14.3.7. Market Revenue and Forecast, by Distribution Channel
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Device Type
14.3.8.2. Market Revenue and Forecast, by Component
14.3.8.3. Market Revenue and Forecast, by Treatment Type
14.3.8.4. Market Revenue and Forecast, by End User
14.3.8.5. Market Revenue and Forecast, by Age Group
14.3.8.6. Market Revenue and Forecast, by Connectivity and Integration
14.3.8.7. Market Revenue and Forecast, by Distribution Channel
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Device Type
14.3.9.2. Market Revenue and Forecast, by Component
14.3.9.3. Market Revenue and Forecast, by Treatment Type
14.3.9.4. Market Revenue and Forecast, by End User
14.3.9.5. Market Revenue and Forecast, by Age Group
14.3.9.6. Market Revenue and Forecast, by Connectivity and Integration
14.3.9.7. Market Revenue and Forecast, by Distribution Channel
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Device Type
14.3.10.2. Market Revenue and Forecast, by Component
14.3.10.3. Market Revenue and Forecast, by Treatment Type
14.3.10.4. Market Revenue and Forecast, by End User
14.3.10.5. Market Revenue and Forecast, by Age Group
14.3.10.6. Market Revenue and Forecast, by Connectivity and Integration
14.3.10.7. Market Revenue and Forecast, by Distribution Channel
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Device Type
14.3.11.2. Market Revenue and Forecast, by Component
14.3.11.3. Market Revenue and Forecast, by Treatment Type
14.3.11.4. Market Revenue and Forecast, by End User
14.3.11.5. Market Revenue and Forecast, by Age Group
14.3.11.6. Market Revenue and Forecast, by Connectivity and Integration
14.3.11.7. Market Revenue and Forecast, by Distribution Channel
14.4. MEA
14.4.1. Market Revenue and Forecast, by Device Type
14.4.2. Market Revenue and Forecast, by Component
14.4.3. Market Revenue and Forecast, by Treatment Type
14.4.4. Market Revenue and Forecast, by End User
14.4.5. Market Revenue and Forecast, by Age Group
14.4.6. Market Revenue and Forecast, by Connectivity and Integration
14.4.7. Market Revenue and Forecast, by Distribution Channel
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Device Type
14.4.8.2. Market Revenue and Forecast, by Component
14.4.8.3. Market Revenue and Forecast, by Treatment Type
14.4.8.4. Market Revenue and Forecast, by End User
14.4.8.5. Market Revenue and Forecast, by Age Group
14.4.8.6. Market Revenue and Forecast, by Connectivity and Integration
14.4.8.7. Market Revenue and Forecast, by Distribution Channel
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Device Type
14.4.9.2. Market Revenue and Forecast, by Component
14.4.9.3. Market Revenue and Forecast, by Treatment Type
14.4.9.4. Market Revenue and Forecast, by End User
14.4.9.5. Market Revenue and Forecast, by Age Group
14.4.9.6. Market Revenue and Forecast, by Connectivity and Integration
14.4.9.7. Market Revenue and Forecast, by Distribution Channel
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Device Type
14.4.10.2. Market Revenue and Forecast, by Component
14.4.10.3. Market Revenue and Forecast, by Treatment Type
14.4.10.4. Market Revenue and Forecast, by End User
14.4.10.5. Market Revenue and Forecast, by Age Group
14.4.10.6. Market Revenue and Forecast, by Connectivity and Integration
14.4.10.7. Market Revenue and Forecast, by Distribution Channel
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Device Type
14.4.11.2. Market Revenue and Forecast, by Component
14.4.11.3. Market Revenue and Forecast, by Treatment Type
14.4.11.4. Market Revenue and Forecast, by End User
14.4.11.5. Market Revenue and Forecast, by Age Group
14.4.11.6. Market Revenue and Forecast, by Connectivity and Integration
14.4.11.7. Market Revenue and Forecast, by Distribution Channel
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Device Type
14.5.2. Market Revenue and Forecast, by Component
14.5.3. Market Revenue and Forecast, by Treatment Type
14.5.4. Market Revenue and Forecast, by End User
14.5.5. Market Revenue and Forecast, by Age Group
14.5.6. Market Revenue and Forecast, by Connectivity and Integration
14.5.7. Market Revenue and Forecast, by Distribution Channel
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Device Type
14.5.8.2. Market Revenue and Forecast, by Component
14.5.8.3. Market Revenue and Forecast, by Treatment Type
14.5.8.4. Market Revenue and Forecast, by End User
14.5.8.5. Market Revenue and Forecast, by Age Group
14.5.8.6. Market Revenue and Forecast, by Connectivity and Integration
14.5.8.7. Market Revenue and Forecast, by Distribution Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Device Type
14.5.9.2. Market Revenue and Forecast, by Component
14.5.9.3. Market Revenue and Forecast, by Treatment Type
14.5.9.4. Market Revenue and Forecast, by End User
14.5.9.5. Market Revenue and Forecast, by Age Group
14.5.9.6. Market Revenue and Forecast, by Connectivity and Integration
14.5.9.7. Market Revenue and Forecast, by Distribution Channel
15.1. Medtronic
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Insulet Corporation
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Tandem Diabetes Care
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Dexcom
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Abbott Laboratories
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Beta Bionics
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Senseonics Holdings
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Roche Diabetes Care
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Ypsomed
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. EOFlow
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
